Cove Street Capital LLC 13D and 13G filings for Lifecore Biomedical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-08-15 5:07 pm Sale |
2023-08-15 | 13D | Lifecore Biomedical, Inc. LFCR |
Cove Street Capital LLC | 1,583,440 5.150% |
-791,325 (-33.32%) |
Filing |
| 2023-01-12 4:23 pm Purchase |
2023-01-12 | 13D | Lifecore Biomedical, Inc. LFCR |
Cove Street Capital LLC | 2,374,765 7.890% |
578,401 (+32.20%) |
Filing |
| 2022-02-11 3:36 pm Purchase |
2021-12-31 | 13G | Lifecore Biomedical, Inc. LFCR |
Cove Street Capital LLC | 1,796,364 6.090% |
187,746 (+11.67%) |
Filing |
| 2021-03-25 4:27 pm Purchase |
2021-03-25 | 13G | Lifecore Biomedical, Inc. LFCR |
Cove Street Capital LLC | 1,608,618 5.490% |
1,608,618 (New Position) |
Filing |